Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants

References

• Sharafutdinov IS, Trizna EY, Baidamshina DR, et al. Antimicrobial effects of sulfonyl derivative of 2(5H)-furanone against planktonic and biofilm associated methicillin-resistant and -susceptible Staphylococcus aureus. Front Microbiol. 2017;8:2246. doi:10.3389/fmicb.2017.0224629209288
   PubMed Web of Science ®Google Scholar
• Lee AS, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4(1):18033. doi:10.1038/nrdp.2018.3329849094
   PubMed Web of Science ®Google Scholar
• Bassetti M, Carnelutti A, Righi E. The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections. Curr Opin Infect Dis. 2017;30(2):150–157. doi:10.1097/QCO.000000000000035328079631
   PubMed Web of Science ®Google Scholar
• Roch M, Varela MC, Taglialegna A, Rose WE, Rosato AE. Activity of telavancin against Staphylococcus aureus isolates, including those with decreased susceptibility to ceftaroline, from cystic fibrosis patients. Antimicrob Agents Chemother. 2018;62(9). doi:10.1128/AAC.00956-18
   Web of Science ®Google Scholar
• Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279(19):1537–1541. doi:10.1001/jama.279.19.15379605897
   PubMed Web of Science ®Google Scholar
• Tshefu K, Zimmerli W, Waldvogel FA. Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis. 1983;5(Suppl 3):S474–80. doi:10.1093/clinids/5.supplement_3.s4746356279
   PubMedGoogle Scholar
• Wouthuyzen-Bakker M, Tornero E, Morata L, et al. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus. Int J Antimicrob Agents. 2018;51(1):38–42. doi:10.1016/j.ijantimicag.2017.04.01128668678
   PubMed Web of Science ®Google Scholar
• Melendez-Carmona MA, Munoz-Gallego I, Viedma E, Lora-Tamayo J, Chaves F. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection. Int J Antimicrob Agents. 2019;54(3):356–360. doi:10.1016/j.ijantimicag.2019.06.01831254616
   PubMed Web of Science ®Google Scholar
• Albrecht J, Baine PA, Ladizinski B, Jemec GB, Bigby M. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A critically appraised topic. Br J Dermatol. 2019;180(4):749–755. doi:10.1111/bjd.1726530281779
   PubMed Web of Science ®Google Scholar
• Ju O, Woolley M, Gordon D. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit. Eur J Clin Microbiol Infect Dis. 2006;25(1):61–62. doi:10.1007/s10096-005-0063-116331332
   PubMed Web of Science ®Google Scholar
• Zhou YF, Xiong YQ, Tao MT, et al. Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA. J Antimicrob Chemother. 2018;73(7):1899–1907. doi:10.1093/jac/dky12929897466
   PubMed Web of Science ®Google Scholar
• Campbell EA, Korzheva N, Mustaev A, et al. Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell. 2001;104(6):901–912. doi:10.1016/s0092-8674(01)00286-011290327
   PubMed Web of Science ®Google Scholar
• Gao W, Cameron DR, Davies JK, et al. The RpoB H(4)(8)(1)Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J Infect Dis. 2013;207(6):929–939. doi:10.1093/infdis/jis77223255563
   PubMed Web of Science ®Google Scholar
• Guerillot R, Goncalves da Silva A, Monk I, et al. Convergent evolution driven by rifampin exacerbates the global burden of drug-resistant Staphylococcus aureus. mSphere. 2018;3(1). doi:10.1128/mSphere.00550-17
   Web of Science ®Google Scholar
• Proctor RA, von Eiff C, Kahl BC, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol. 2006;4(4):295–305. doi:10.1038/nrmicro138416541137
   PubMed Web of Science ®Google Scholar
• Kahl BC, Becker K, Loffler B. Clinical significance and pathogenesis of staphylococcal small colony variants in persistent infections. Clin Microbiol Rev. 2016;29(2):401–427. doi:10.1128/CMR.00069-1526960941
   PubMed Web of Science ®Google Scholar
• Wong Fok Lung T, Monk IR, Acker KP, et al. Staphylococcus aureus small colony variants impair host immunity by activating host cell glycolysis and inducing necroptosis. Nat Microbiol. 2020;5(1):141–153. doi:10.1038/s41564-019-0597-031686028
   PubMed Web of Science ®Google Scholar
• Proctor R. Respiration and small colony variants of Staphylococcus aureus. Microbiol Spectr. 2019;7(3). doi:10.1128/microbiolspec.GPP3-0069-2019
   Web of Science ®Google Scholar
• Lim KT, Teh CS, Yusof MY, Thong KL. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia. Trans R Soc Trop Med Hyg. 2014;108(2):112–118. doi:10.1093/trstmh/trt11124336696
   PubMed Web of Science ®Google Scholar
• Zhi S, Banting G, Li Q, et al. Evidence of naturalized stress-tolerant strains of Escherichia coli in municipal wastewater treatment plants. Appl Environ Microbiol. 2016;82(18):5505–5518. doi:10.1128/AEM.00143-1627371583
   PubMed Web of Science ®Google Scholar
• Compernolle V, Verschraegen G, Claeys G. Combined use of pastorex staph-plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2007;45(1):154–158. doi:10.1128/JCM.01115-0617093032
   PubMed Web of Science ®Google Scholar
• Pino A, Russo N, Van Hoorde K, et al. Piacentinu ennese PDO cheese as reservoir of promising probiotic bacteria. Microorganisms. 2019;7(8):254. doi:10.3390/microorganisms7080254
   Web of Science ®Google Scholar
• Wellinghausen N, Chatterjee I, Berger A, et al. Characterization of clinical Enterococcus faecalis small-colony variants. J Clin Microbiol. 2009;47(9):2802–2811. doi:10.1128/JCM.00485-0919605585
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standard for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020
   Google Scholar
• Tang YT, Cao R, Xiao N, et al. Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates in Xiangyang, China. J Glob Antimicrob Resist. 2018;12:31–36. doi:10.1016/j.jgar.2017.08.01628887291
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang T, Guo Y, et al. In vitro/vivo activity of potential MCR-1 inhibitor in combination with colistin againsts mcr-1-positive Klebsiella pneumonia. Front Microbiol. 2018;9:1615. doi:10.3389/fmicb.2018.0161530065720
   PubMed Web of Science ®Google Scholar
• Rossi Goncalves I, Dantas RCC, Ferreira ML, et al. Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation. Braz J Microbiol. 2017;48(2):211–217. doi:10.1016/j.bjm.2016.11.00428034598
   PubMed Web of Science ®Google Scholar
• Tsai CJ, Loh JM, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016;7(3):214–229. doi:10.1080/21505594.2015.113528926730990
   PubMed Web of Science ®Google Scholar
• Gao W, Chua K, Davies JK, et al. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog. 2010;6(6):e1000944. doi:10.1371/journal.ppat.100094420548948
   PubMed Web of Science ®Google Scholar
• Howden BP, McEvoy CR, Allen DL, et al. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog. 2011;7(11):e1002359. doi:10.1371/journal.ppat.100235922102812
   PubMed Web of Science ®Google Scholar
• Tenover FC, Sinner SW, Segal RE, et al. Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy. Int J Antimicrob Agents. 2009;33(6):564–568. doi:10.1016/j.ijantimicag.2008.12.01019233622
   PubMed Web of Science ®Google Scholar
• Tuchscherr L, Medina E, Hussain M, et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med. 2011;3(3):129–141. doi:10.1002/emmm.20100011521268281
   PubMed Web of Science ®Google Scholar
• Garcia LG, Lemaire S, Kahl BC, et al. Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother. 2012;56(7):3700–3711. doi:10.1128/AAC.00285-1222564838
   PubMed Web of Science ®Google Scholar
• Wang C, Fang R, Zhou B, et al. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro. BMC Microbiol. 2019;19(1):220. doi:10.1186/s12866-019-1573-931533633
   PubMed Web of Science ®Google Scholar
• Yilmaz ES, Aslantas O. Antimicrobial resistance and underlying mechanisms in Staphylococcus aureus isolates. Asian Pac J Trop Med. 2017;10(11):1059–1064. doi:10.1016/j.apjtm.2017.10.00329203102
   PubMed Web of Science ®Google Scholar
• Tang HJ, Lai CC, Hsueh PR, et al. RNA polymerase B subunit gene mutations in biofilm-embedded methicillin-resistant Staphylococcus aureus following rifampin treatment. J Microbiol Immunol Infect. 2016;49(3):394–401. doi:10.1016/j.jmii.2015.06.00626303044
   PubMedGoogle Scholar
• von Eiff C. Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians. Int J Antimicrob Agents. 2008;31(6):507–510. doi:10.1016/j.ijantimicag.2007.10.02618180148
   PubMed Web of Science ®Google Scholar
• Garcia LG, Lemaire S, Kahl BC, et al. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J Antimicrob Chemother. 2013;68(7):1455–1464. doi:10.1093/jac/dkt07223485724
   PubMed Web of Science ®Google Scholar
• Idelevich EA, Kriegeskorte A, Stubbings W, et al. Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes. J Antimicrob Chemother. 2011;66(12):2809–2813. doi:10.1093/jac/dkr39321948963
   PubMed Web of Science ®Google Scholar
• von Eiff C, Friedrich AW, Becker K, Peters G. Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. Antimicrob Agents Chemother. 2005;49(10):4372–4374. doi:10.1128/AAC.49.10.4372-4374.200516189125
   PubMed Web of Science ®Google Scholar
• Tuchscherr L, Kreis CA, Hoerr V, et al. Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis. J Antimicrob Chemother. 2016;71(2):438–448. doi:10.1093/jac/dkv37126589581
   PubMed Web of Science ®Google Scholar
• Kriegeskorte A, Grubmuller S, Huber C, et al. Staphylococcus aureus small colony variants show common metabolic features in central metabolism irrespective of the underlying auxotrophism. Front Cell Infect Microbiol. 2014;4:141. doi:10.3389/fcimb.2014.0014125374845
   PubMed Web of Science ®Google Scholar
• Mitchell G, Brouillette E, Seguin DL, et al. A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Microb Pathog. 2010;48(1):18–27. doi:10.1016/j.micpath.2009.10.00319825410
   PubMed Web of Science ®Google Scholar
• Kriegeskorte A, Block D, Drescher M, et al. Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression. mBio. 2014;5(4):e01447–14. doi:10.1128/mBio.01447-1425073642
   PubMed Web of Science ®Google Scholar